771
Views
12
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland

, , , , , & show all
Pages 834-838 | Received 03 Mar 2015, Accepted 08 Mar 2015, Published online: 29 May 2015

References

  • Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999; 125:149-52; PMID:10037280; http://dx.doi.org/10.1001/archotol.125.2.149
  • Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer 2001; 96:149-58; PMID:11410883; http://dx.doi.org/10.1002/ijc.1013
  • Peruzzi B, Bottaro DP. Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 2006; 12:3657-60; PMID:16778093; http://dx.doi.org/10.1158/1078-0432.CCR-06-0818
  • Suzuki K, Cheng J, Watanabe Y. Hepatocyte growth factor and c-Met (HGF/c-Met) in adenoid cystic carcinoma of the human salivary gland. J Oral Pathol Med 2003; 32:84-9; PMID:12542830; http://dx.doi.org/10.1034/j.1600-0714.2003.00018.x
  • Li J, Perlaky L, Rao P, Weber RS, El-Naggar AK. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol 2014; 50:991-9; PMID:25086988; http://dx.doi.org/10.1016/j.oraloncology.2014.06.012
  • Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012; 12:89-103; PMID:22270953; http://dx.doi.org/10.1038/nrc3205
  • Koeppen H, Rost S, Yauch RL. Developing biomarkers to predict benefit from HGF/MET pathway inhibitors. J Pathol 2014; 232:210-8; PMID:24105670; http://dx.doi.org/10.1002/path.4268
  • Lacroix L, Post SF, Valent A, Melkane AE, Vielh P, Egile C, Castell C, Larois C, Micallef S, Saulnier P, et al. MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma. PloS one 2014; 9:e84319; PMID:24465403; http://dx.doi.org/10.1371/journal.pone.0084319
  • Gao H, Guan M, Sun Z, Bai C. High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis. Tumour Biol 2015; 36:515-20; PMID:25636446; http://dx.doi.org/10.1007/s13277-014-2659-5
  • Baschnagel AM, Mangona VS, Robertson JM, Welsh RJ, Kestin LL, Grills IS. Lung metastases treated with image-guided stereotactic body radiation therapy. Clinical oncology 2013; 25:236-41; PMID:23352916; http://dx.doi.org/10.1016/j.clon.2012.12.005
  • Koh YW, Lee HJ, Ahn JH, Lee JW, Gong G. MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. Pathol Res Pract 2014; 210:494-500; PMID:24814255; http://dx.doi.org/10.1016/j.prp.2014.04.002
  • Kowalczuk O, Kozlowski M, Niklinska W, Kisluk J, Niklinska BJ, Niklinski J. Increased MET gene copy number but not mRNA level predicts postoperative recurrence in patients with non-small cell lung cancer. Translational oncology 2014; 7:605-12; PMID:25389455; http://dx.doi.org/10.1016/j.tranon.2014.08.002
  • Kwon MJ, Kim DH, Park HR, Shin HS, Kwon JH, Lee DJ, Kim JH, Cho SJ, Nam ES. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances. Hum Pathol 2014; 45:1327-38; PMID:24810547; http://dx.doi.org/10.1016/j.humpath.2014.03.003

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.